| mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
5e-07 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
7e-07 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
| mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-06 |
| mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
5e-06 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.22 |
5e-05 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |